Patient | SIU School of Medicine

News

SIU's Correctional Medicine joins DoD Skillbridge program

SIU's Office of Correctional Medicine has joined the U.S. Department of Defense SkillBridge Program as an industry partner, creating new opportunities for transitioning service members and military spouses.

News

SIU's Correctional Medicine joins DoD Skillbridge program

News

Dr. Erin Hascup discusses Alzheimer's research, 'Illuminate the Night' on AM Springfield

Smith Alzheimer's Center executive director Erin Hascup, PhD, joined AM Springfield to discuss the prevalence of Alzheimer's, an update to the Center's activities, the current state of research, as well as an exciting announcement of the event, Illuminate the Night . Timestamps for interview segments: Overview of Alzheimer's and dementia: 18:50 - 27:05 Update on research and upcoming events: 46:25 - 54:30 To learn more about Erin Hascup's lab, including research focus, publications, team members, and more, visit her lab page .

Events

SIU School of Medicine Day of Giving 2025

Join us for #SIUSOM Day of Giving 2025—a day dedicated to making a difference! Together, we can support the students, programs, and community initiatives that make SIU Medicine an integral part of improving health and transforming lives. With your help, we will continue to provide innovative research, compassionate patient care, and top-tier education. Every gift matters and helps fuel the mission of SIU Medicine. How to Participate Visit our giving page on forwardfunder.siumed.edu. Choose the cause or fund that means the most to you. Share your support on social media using #SIUSOM Day of

News

Announcing “Illuminate the Night” to support Alzheimer’s care and research

The Dale and Deborah Smith Center for Alzheimer’s Research and Treatment is proud to announce the inaugural Illuminate the Night , an evening dedicated to raising funds for Alzheimer’s care, research, and outreach programs. Scheduled for June 14, 2025 at Crowne Plaza in Springfield, IL, this unforgettable event will feature entertainment, a live auction and a chance for the community to make a meaningful impact. Illuminate the Night brings together donors, caregivers and community members with a shared mission: to brighten the path for individuals living with dementia and their loved ones. The

News

Alzheimer’s is more than just memory loss

Agitation and behavior changes can shape Alzheimer’s journey For many, memory loss is the hallmark sign of Alzheimer’s and dementia. But dementia does more than cloud memory. It can alter how people communicate, change their personality and attitude and lead to agitation or erratic behavior. Dementia can cause lack of judgement, a lack of empathy or difficulty in interpreting and communicating feelings. Neither the person nor the behavior is the problem—the issue often lies in an unmet need or emotion that the person is trying to communicate. There are many kinds of dementia. And in turn, each

Locations

Beth's Rx Café

825 N Rutledge St. Springfield, IL 62702

Get Directions

Mon - Fri: 7:00 am-3:00 pm

Trial

Simmons Cancer Institute

A Phase 1 Study of SGN-B6A in Advanced Solid Tumors

Active recruiting

This trial looks at a drug called sigvotatug vedotin (SGN-B6A) alone and with pembrolizumab, with or without chemotherapy, to find out whether it is safe for people who have solid tumors (NSCLC, HNSCC).

Trial

Urology

A Randomized Open-Label Phase 2/3 Study of BT8009 Monotherapy or in Combination in Participants with Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)

Active recruiting

The main objective of the study is to measure how safe and effective BT8009 (zelenectide pevedotin) is when used alone and in combination with pembrolizumab in participants with locally advanced or metastatic urothelial cancer (UC).

Trial

Internal Medicine

THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System vs. Sham for the Adjunctive Treatment of Hypertension

Active recruiting

The purpose of this clinical trial is to assess whether a medical device called the TIVUS System can lower high blood pressure in patients who are known to have hypertension.

Eligible patients include those who currently have a diagnosis of high blood pressure despite having taken or currently taking anti-hypertensive medications.

Subscribe to Patient